The old CCE company had difficulty in getting the USA trial moving in the right direction due to large number of patients required that had to be included by the FDA. VSG had more experience and success with the FDA and this was a postive iro of the merger for CCE.
SO...... Some information about the trial would be most welcome. How many patients do they require now? There was some talk of negotiating the number downwards. How many trials have taken place? What are the results like?
The Annual report is light-on with detail in these important areas.IMO
Anyone in the know?
it would appear that the respiratoty sales will increase progresively over time but the SP will really get a kick along with USA/FDA approval and subsequent sales.
recell clinical trial in usa
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
-0.050(2.02%) |
Mkt cap ! $160.4M | |||
| Open | High | Low | Value | Volume |
| $2.43 | $2.44 | $2.38 | $769.7K | 319.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5463 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.44 | 8000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| AVH (ASX) Chart |